Fredun Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 17-09-2024
- Paid Up Capital ₹ 4.72 Cr
as on 17-09-2024
- Company Age 37 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 252.88 Cr
as on 17-09-2024
- Satisfied Charges ₹ 57.16 Cr
as on 17-09-2024
- Revenue 22.30%
(FY 2023)
- Profit 70.58%
(FY 2023)
- Ebitda 150.86%
(FY 2023)
- Net Worth 41.60%
(FY 2023)
- Total Assets 37.59%
(FY 2023)
About Fredun Pharmaceuticals
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 539730.
The Corporate was formerly known as Fredun Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 4.72 Cr.
The company currently has active open charges totaling ₹252.88 Cr. The company has closed loans amounting to ₹57.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Fredun Pharmaceuticals Ltd India are Fredun Medhora as CFO and Jinkal Shah as Company Secretary. Daulat Medhora, Fredun Medhora, Nariman Medhora, and Three other members serve as directors at the Company.
- CIN/LLPIN
L24239MH1987PLC043662
- Company No.
043662
- Stock Symbol
BSE : 539730
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jun 1987
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Fredun Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Fredun Medhora  | Managing Director | 15-Sep-2006 | Current |
| Jinkal Shah | Company Secretary | 28-Jan-2022 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Daulat Medhora | Whole-Time Director | 08-Jun-1987 | Current |
| Nariman Medhora | Director | 08-Jun-1987 | Current |
| Aspi Raimalwala | Director | 30-Sep-2015 | Current |
| Rohinton Kanga | Director | 30-Sep-2015 | Current |
| Daisy Dsouza | Director | Current |
Financial Performance and Corporate Structure Insights of Fredun Pharmaceuticals.
Fredun Pharmaceuticals Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 22.3% increase. The company also saw a substantial improvement in profitability, with a 70.58% increase in profit. The company's net worth Soared by an impressive increase of 41.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fredun Pharmaceuticals?
In 2022, Fredun Pharmaceuticals had a promoter holding of 51.27% and a public holding of 48.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fredun Healthcare Private LimitedActive 16 years 7 monthsFredun Medhora and Nariman Medhora are mutual person
Fredna Enterprises Private LimitedActive 3 years 8 monthsDaulat Medhora, Fredun Medhora and 1 more are mutual person
- Iteeha Hospitality & Entertainment Private LimitedActive 1 year 3 months
Fredun Medhora is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 May 2024 | ₹7.19 M | Open |
Others Creation Date: 29 Apr 2024 | ₹5.94 M | Open |
Others Creation Date: 25 Apr 2024 | ₹6.90 M | Open |
How Many Employees Work at Fredun Pharmaceuticals?
Fredun Pharmaceuticals has a workforce of 233 employees as of Sep 17, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fredun Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fredun Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
